Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel Glycosylated Epitope on Cancer Cell Surface (NA)
- Target
- NA
- Molecular classification
- Carbohydrate, Glycoprotein, Glycolipid, Epitope, Cell Surface Antigen
01
Overview
A novel glycosylated epitope on the cancer cell surface refers to a unique carbohydrate structure (glycoepitope) present on proteins or lipids that is specifically altered or overexpressed in cancer cells compared to normal tissues. These epitopes are often the result of aberrant glycosylation, a hallmark of malignant transformation. They contribute to tumor progression, metastasis, immune evasion, and modulation of receptor signaling and adhesion molecule function. Tumor-restricted glycoepitopes serve as biomarkers and therapeutic targets for monoclonal antibody-based therapies.
- Other names
- Cancer-Associated GlycanTumor-Specific GlycoepitopeAberrant GlycosylationTumor-Restricted Glycoepitope
02
Mechanism of action
Targeted binding of monoclonal antibodies to tumor-specific glycoepitopes, leading to cell death or immune-mediated tumor destruction.
03
Biological functions
Immune evasionMetastasis facilitationCell adhesionReceptor signaling modulationTumor progression
04
Disease associations
CancerTumorigenesisMetastasis
05
Safety considerations
Off-target toxicityImmunogenicityDevelopment of resistance
06
Interacting drugs
PODO447 mAb
1 more in the full profile.
07
Biomarkers
Sialyl Lewis xTn antigenβ1–6 branched N-glycanTumor-Podxl Glycoform
Beyond the preview
Go deeper on Novel Glycosylated Epitope on Cancer Cell Surface (NA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel Glycosylated Epitope on Cancer Cell Surface (NA).